Pemigatinib in Chinese patients with advanced/metastatic or surgically unresecta

Discussion Board Forums Clinical Trials Pemigatinib in Chinese patients with advanced/metastatic or surgically unresecta

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #101714
    gavin
    Moderator

    Pemigatinib in Chinese patients with advanced/metastatic or surgically unresectable cholangiocarcinoma including FGFR2 fusion or rearrangement: Updated data from an open-label, single-arm, multicenter phase II study (CIBI375A201 study).

    https://meetings.asco.org/abstracts-presentations/212069

Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.